This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Brazilian pharmaproduction sites are involved in Covid-19 vaccine and therapy manufacture. Large Brazilian pharma companies already play a major role in distributing Covid-19 vaccines to all of Latin America. Eurofarma will obtain the drug product from facilities in the US.
Also known as lyophilisation, the technique stabilises and preserves sensitive products such as biologics, and diagnostic kits, in a permanently storable state. The companies offer systems for more dynamic freeze-drying of products with more precision in control.
Soon after the invasion, the president of Bavaria announced that the German state would no longer allow Russia's Covid-19 vaccine, Sputnik V, to be produced at a facility in the region. The region had signed a letter of intent in April last year with the vaccine’s financial backer, the Russian Direct Investment Fund (RDIF), to purchase 2.5
Dealing with different regulations and stakeholders across diverse regions means there are many points in the journey where something can go wrong. Given these potential vulnerabilities, visibility is essential for organisations seeking to accurately track their products and ensure they are safe to use.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content